Exome-wide analysis has revealed increased burden of predicted deleterious GCH1 mutations in PD patients [8–10], and genome-wide association studies (GWAS) have identified associations of polymorphisms in GCH1 locus with PD [11, 12]. Here, GCH1 is linked to Parkinson disease.